Cargando…

Mitochondrial Drugs for Alzheimer Disease

Therapeutic strategies for Alzheimer disease (AD) have yet to offer a disease-modifying effect to stop the debilitating progression of neurodegeneration and cognitive decline. Rather, treatments thus far are limited to agents that slow disease progression without halting it, and although much work t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonda, David J., Wang, Xinglong, Gustaw-Rothenberg, Katarzyna A., Perry, George, Smith, Mark A., Zhu, Xiongwei
Formato:	Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909133/ https://www.ncbi.nlm.nih.gov/pubmed/20657666 http://dx.doi.org/10.3390/ph2030287

Ejemplares similares

Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis
por: Jiang, Zhen, et al.
Publicado: (2015)

Dietary Patterns Associated with Alzheimer’s Disease: Population Based Study
por: Gustaw-Rothenberg, Katarzyna
Publicado: (2009)

Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches
por: Castellani, Rudy J., et al.
Publicado: (2009)

Early Induction of Oxidative Stress in Mouse Model of Alzheimer Disease with Reduced Mitochondrial Superoxide Dismutase Activity
por: Lee, Hyun-Pil, et al.
Publicado: (2012)

Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
por: Wang, Wenzhang, et al.
Publicado: (2020)

Estrogen receptor-α is localized to neurofibrillary tangles in Alzheimer’s disease
por: Wang, Chunyu, et al.
Publicado: (2016)

Posttranslational modifications of α-tubulin in alzheimer disease
por: Zhang, Fan, et al.
Publicado: (2015)

Phosphorylation of Tau Protein as the Link between Oxidative Stress, Mitochondrial Dysfunction, and Connectivity Failure: Implications for Alzheimer's Disease
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2013)

Heme Deficiency in Alzheimer's Disease: A Possible Connection to Porphyria
por: Dwyer, Barney E., et al.
Publicado: (2006)

Amyloid Beta and Tau Proteins as Therapeutic Targets for Alzheimer's Disease Treatment: Rethinking the Current Strategy
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2012)

A Novel Origin for Granulovacuolar Degeneration in Aging and Alzheimer’s Disease: Parallels to Stress Granules
por: Castellani, Rudy J., et al.
Publicado: (2011)

Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease
por: Bryan, Kathryn J, et al.
Publicado: (2008)

Treatment advances in Alzheimer's disease based on the oxidative stress model
por: Friedlich, Avi L, et al.
Publicado: (2009)

Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease
por: Casadesus, Gemma, et al.
Publicado: (2007)

Glycogen Synthase Kinase 3: A Point of Integration in Alzheimer's Disease and a Therapeutic Target?
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2012)

Deconstructing Mitochondrial Dysfunction in Alzheimer Disease
por: García-Escudero, Vega, et al.
Publicado: (2013)

Alzheimer's Disease and Vascular Deficiency: Lessons from Imaging Studies and Down Syndrome
por: Reed-Cossairt, Arlene, et al.
Publicado: (2012)

Alzheimer Disease and Oxidative Stress
por: Perry, George, et al.
Publicado: (2002)

BRCA1 May Modulate Neuronal Cell Cycle Re-Entry in Alzheimer Disease
por: Evans, Teresa A., et al.
Publicado: (2007)

Neurodegenerative Diseases: Mechanisms and Therapies
por: Smith, Mark A., et al.
Publicado: (2006)

Mitochondrial Dysfunction in Atrial Fibrillation—Mechanisms and Pharmacological Interventions
por: Muszyński, Paweł, et al.
Publicado: (2021)

Antimicrobial peptide β-defensin-1 expression is upregulated in Alzheimer’s brain
por: Williams, Wesley M, et al.
Publicado: (2013)

Oxidative Damage to RNA in Neurodegenerative Diseases
por: Nunomura, Akihiko, et al.
Publicado: (2006)

Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease
por: Bonda, David J., et al.
Publicado: (2009)

Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets
por: Cardoso, Susana, et al.
Publicado: (2009)

Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease
por: Clark, Timothy A., et al.
Publicado: (2010)

Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease
por: Austad, Steven N., et al.
Publicado: (2022)

Parkinson’s disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes
por: Wang, Wenzhang, et al.
Publicado: (2015)

Steroidogenic Acute Regulatory Protein (StAR): Evidence of Gonadotropin-Induced Steroidogenesis in Alzheimer Disease
por: Webber, Kate M, et al.
Publicado: (2006)

Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in alzheimer’s disease brain
por: Wang, Wenzhang, et al.
Publicado: (2023)

Dysfunctional tubular endoplasmic reticulum constitutes a pathological feature of Alzheimer’s disease
por: Sharoar, Md. Golam, et al.
Publicado: (2015)

Mitochondrial Preconditioning: A Potential Neuroprotective Strategy
por: Correia, Sónia C., et al.
Publicado: (2010)

Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases
por: Gao, Ju, et al.
Publicado: (2017)

Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease
por: Su, Bo, et al.
Publicado: (2009)

Mislocalization of CDK11/PITSLRE, a regulator of the G2/M phase of the cell cycle, in Alzheimer disease
por: Bajić, Vladan P., et al.
Publicado: (2011)

Hypoperfusion, Mitochondria Failure, Oxidative Stress, and Alzheimer Disease
por: Aliev, Gjumrakch, et al.
Publicado: (2003)

Neurofilamentopathy in Neurodegenerative Diseases
por: Liu, Quan, et al.
Publicado: (2011)

Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
por: Hoekstra, Jake G, et al.
Publicado: (2011)

Mitochondrial Haplotypes Associated with Biomarkers for Alzheimer’s Disease
por: Ridge, Perry G., et al.
Publicado: (2013)

Polyphenols in Alzheimer’s Disease and in the Gut–Brain Axis
por: Reddy, V. Prakash, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_37l50gtfcmh62t3b8iqd4snbmg